Synthesis, structure and spectroscopic properties of some thiosemicarbazone complexes of platinum

[1]  W. Sheldrick,et al.  Synthesis, structure and electrochemical properties of some thiosemicarbazone complexes of iridium , 2007 .

[2]  R. Singh,et al.  Structural Studies with Antimicrobial and Antifertility Activity of a Monofunctional Bidentate Ligand with its Boron(III), Palladium(II), and Platinum(II) Complexes , 2006 .

[3]  H. Beraldo,et al.  Platinum and palladium complexes of thiosemicarbazones derived of 2-acetylthiophene: Synthesis and spectral studies. , 2006, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[4]  S. Peng,et al.  Rhodium assisted C-H activation of benzaldehyde thiosemicarbazones and their oxidation via activation of molecular oxygen. , 2006, Inorganic chemistry.

[5]  S. Padhye,et al.  Antiproliferative activities of iron and platinum conjugates of salicylaldehyde semi-/thiosemicarbazones against C6 glioma cells. , 2005, European journal of medicinal chemistry.

[6]  F. Avilés,et al.  New palladium(II) and platinum(II) complexes with the model nucleobase 1-methylcytosine: antitumor activity and interactions with DNA. , 2005, Inorganic chemistry.

[7]  Y. Naruta,et al.  Cyclopalladation of the indole ring in palladium(II) complexes of 2N1O-donor ligands and its dependence on the O-donor properties. , 2005, Inorganic chemistry.

[8]  S. Prasad,et al.  Synthesis and Spectral Investigations of Some Platinum Metals Ions Coordination Compounds of 4[N-(Furan-2'-carboxalidene)Amino]Antipyrine Thiosemicarbazone and 4[N-(3',4',5'-Trimethoxybenzalidene)Amino]Antipyrine Thiosemicarbazone , 2005 .

[9]  N. D. Jones,et al.  Platinum(II) and palladium(II) complexes of bisphosphine ligands bearing o-N,N-dimethylanilinyl substituents: a hint of catalytic olefin hydration. , 2005, Inorganic chemistry.

[10]  K. Mehta,et al.  Antitumor metallothiosemicarbazonates: structure and antitumor activity of palladium complex of phenanthrenequinone thiosemicarbazone. , 2005, Inorganic chemistry.

[11]  A. E. Liberta,et al.  Antifungal and antitumor activity of heterocyclic thiosemicarbazones and their metal complexes: current status , 2005, Biometals.

[12]  E. Siapi,et al.  The thermal effects of platinum(II) and palladium(II) complexes with 2-acetyl pyridine and pyridine-2-carbaldehyde N(4)-ethyl-thiosemicarbazones in membrane bilayers , 2004 .

[13]  S. Skoulika,et al.  Palladium(II) and platinum(II) complexes of 2-hydroxy acetophenone N(4)-ethylthiosemicarbazone – crystal structure and description of bonding properties , 2004 .

[14]  R. Singh,et al.  Stereochemical, biochemical and ligation behaviour of divalent platinum complexes of sulfur and nitrogen donor agents , 2004 .

[15]  John R. Miller,et al.  Platinum(II) and palladium(II) complexes with 2-Acetyl pyridine 4N-ethyl thiosemicarbazone able to overcome the cis-Platin resistance. Structure, antibacterial activity and DNA strand breakage , 2003, Biometals.

[16]  A. Quiroga,et al.  Contribution to the SAR field of metallated and coordination complexes: Studies of the palladium and platinum derivatives with selected thiosemicarbazones as antitumoral drugs , 2004 .

[17]  M. Monshi,et al.  Preparation and Investegation of the Bonding Mode in the Complexes of Pt(II) with Thiosemicarbazone Ligands , 2003 .

[18]  S. Peng,et al.  Synthesis, structure and redox properties of some thiosemicarbazone complexes of rhodium , 2002 .

[19]  F. Basuli,et al.  Thiosemicarbazone complexes of the platinum metals. A story of variable coordination modes , 2002 .

[20]  M. Sassi,et al.  Synthesis, characterization and X-ray structures of new antiproliferative and proapoptotic natural aldehyde thiosemicarbazones and their nickel(II) and copper(II) complexes. , 2002, Journal of inorganic biochemistry.

[21]  G. Bouet,et al.  In vitro and in vivo effects of [Ni(M5FTSC)2Cl2] complex in cancer: preliminary tests. , 2002, Anticancer research.

[22]  J. Dilworth,et al.  An unusual dimeric structure of a Cu(I) bis(thiosemicarbazone) complex: implications for the mechanism of hypoxic selectivity of the Cu(II) derivatives. , 2002, Journal of the American Chemical Society.

[23]  A. Castiñeiras,et al.  Synthesis, solution and spectral studies of palladium(II) complexes with 2-hydroxyacetophenone N(3)-propylthiosemicarbazone. Crystal structure of a tripalladium complex , 2002 .

[24]  C. Reynolds,et al.  Studies on the mechanism of hypoxic selectivity in copper bis(thiosemicarbazone) radiopharmaceuticals. , 2002, Journal of medicinal chemistry.

[25]  Yifan Zheng,et al.  The chemistry and applications of complexes with sulfur ligands , 2002 .

[26]  W. Kaminsky,et al.  Structural Studies of 2,6-Diacetyl- and 2,6-Diformylpyridine Bis(thiosemicarbazones) , 2002 .

[27]  T. Mak,et al.  Synthesis, Structure, and Properties of a Novel Heterooctametallic Complex Containing a Cyclic Ru4 Ni4 Core. , 2001, Angewandte Chemie.

[28]  S. Padhye,et al.  Tuning up superoxide dismutase activity of copper complex of salicylaldehyde semicarbazone by heterocyclic bases pyridine and N-methyl imidazole , 2001 .

[29]  D. Mourelatos,et al.  Platinum(II) and palladium(II) complexes with 2-acetylpyridine thiosemicarbazone: cytogenetic and antineoplastic effects , 2001, Anti-cancer drugs.

[30]  John R. Miller,et al.  Trinuclear Palladium(II) Complexes with 2‐Hydroxy‐4‐methoxyacetophenone N4‐Dimethylthiosemicarbazone: Synthesis, Spectral Studies and Crystal Structure of a Tripalladium Complex , 2000 .

[31]  S. Peng,et al.  Unusual coordination mode of thiosemicarbazone ligands. A search for the origin. , 2000, Inorganic chemistry.

[32]  C. Tessier,et al.  MULTINUCLEAR NMR STUDY AND CRYSTAL STRUCTURES OF COMPLEXES OF THE TYPES CIS- AND TRANS-PT(YPY)2X2, WHERE YPY = PYRIDINE DERIVATIVE AND X = CL AND I , 1999 .

[33]  John R. Miller,et al.  Palladium(II) and platinum(II) complexes of pyridine-2-carbaldehyde thiosemicarbazone with potential biological activity. Synthesis, structure and spectral properties. Extended network via hydrogen bond linkages of [Pd(PyTsc)Cl] , 1999 .

[34]  F. Basuli,et al.  Unusual Coordination Mode of Thiosemicarbazone Ligand. Synthesis, Structure, and Redox Properties of Some Ruthenium and Osmium Complexes. , 1998, Inorganic chemistry.

[35]  I. Hall,et al.  The cytotoxicity of copper(II) complexes of 2-acetyl-pyridyl-4N-substituted thiosemicarbazones. , 1998, Anticancer research.

[36]  A. Castiñeiras,et al.  Spectral and structural studies of metal complexes of 1-phenylglyoxal bis { {N (3) -diethylthiosemicarbazone} } , 1998 .

[37]  S. Peng,et al.  Steric Control of the Coordination Mode of the Salicylaldehyde Thiosemicarbazone Ligand. Syntheses, Structures, and Redox Properties of Ruthenium and Osmium Complexes , 1997 .

[38]  D. Mourelatos,et al.  Antineoplastic and cytogenetic effects of complexes of Pd (II) with 4N-substituted derivatives of 2-acetyl-pyridine-thiosemicarbazone. , 1997, Anticancer research.

[39]  Paul D. Bloom,et al.  Structures and spectral properties of palladium(II) complexes of 2-acetylpyridine N(4)-dimethylthiosemicarbazone , 1996 .

[40]  X. You,et al.  Crystal structure and spectroscopic studies on metal complexes containing ns donor ligands derived from S-benzyldithiocarbazate andp-dimethylaminobenzaldehyde , 1996 .

[41]  R. Butcher,et al.  The preparation and characterization of some copper(II) Complexes of the 6-methyl-2-formylpyridine thiosemicarbazone and the x-ray crystal structure of the chloro(6-methyl-2-formylpyridinethiosemicabazonato) copper(II) complex , 1996 .

[42]  P. Souza,et al.  Copper(II) and cobalt(II) complexes of methyl 2-pyridyl ketone thiosemicarbazone (HL); single-crystal structure of [Cu(HL)L]NCS , 1996 .

[43]  K. I. Goldberg,et al.  Binuclear copper(II) complexes of 2-hydroxyacetophenone 4N-substituted thiosemicarbazones , 1995 .

[44]  C. Raptopoulou,et al.  Coordinating properties of 2-acetylpyridine thiosemicarbazone. Palladium(II) complexes with neutral and deprotonated ligand. X-ray structure of bromo(2-acetylpyridine thiosemicarbazonato) palladium(II) , 1994 .

[45]  R. Crabtree,et al.  Deprotonated thioamides as thiolate S-donor ligands with a high tendency to avoid M-S-M bridge formation: crystal and molecular structure of bis(2-hydroxy-5-methylacetophenone N,N-dimethylthiosemicarbazonato)dinickel , 1993 .

[46]  S. Padhye,et al.  Thiosemicarbazone complexes of copper(II): structural and biological studies , 1993 .

[47]  S. Padhye,et al.  Structural and physical correlations in the biological properties of transition metal heterocyclic thiosemicarbazone and S -alkyldithiocarbazate complexes , 1991 .

[48]  D. Proserpio,et al.  MO theory made visible , 1990 .

[49]  I. Haiduc,et al.  Metal compounds in cancer chemotherapy , 1990 .

[50]  D. Petering,et al.  Reaction of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazonato) Cu(II) with Ehrlich cells. Binding of copper to metallothionein and its relationship to zinc metabolism and cell proliferation. , 1985, The Journal of biological chemistry.

[51]  G. Kauffman,et al.  Transition metal complexes of semicarbazones and thiosemicarbazones , 1985 .

[52]  D. L. Klayman,et al.  2-Acetylpyridine thiosemicarbazones. 4. Complexes with transition metals as antimalarial and antileukemic agents. , 1982, Journal of medicinal chemistry.

[53]  A. Sartorelli,et al.  7 The Chemistry and Biological Activity of α -(N)-Heterocyclic Carboxaldehyde Thiosemicarbazones , 1978 .

[54]  G. Crosby,et al.  Excited states of mixed ligand chelates of ruthenium(II) and rhodium(III) , 1976 .

[55]  J. Pilbrow,et al.  E.S.R. studies of the solute-solute interactions between copper(II) and nickel(II) thiosemicarbazone chelates in non-aqueous solutions , 1976 .

[56]  A. Sartorelli,et al.  Characterization of the biochemical mechanism of action of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones. , 1976, Advances in enzyme regulation.

[57]  M. Campbell.  Transition metal complexes of thiosemicarbazide and thiosemicarbazones , 1975 .

[58]  E. Blanz,et al.  Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VI. 1-Formylisoquinoline derivatives bearing additional ring substituents, with notes on mechanism of action. , 1970, Journal of medicinal chemistry.

[59]  M. Angoletta,et al.  231. Palladium(0) compounds. Part II. Compounds with triarylphosphines, triaryl phosphites, and triarylarsines , 1957 .